Antiviral and antibacterial cantharidin preparation, preparation method thereof and application of antiviral and antibacterial cantharidin preparation in prevention and treatment of novel coronavirus infection
The invention relates to an antiviral and antibacterial cantharidin preparation. The antiviral and antibacterial cantharidin preparation contains cantharidin as an effective drug component, the cantharidin is dissolved in an oil-water mutual solution or an oil-oil mutual solution to obtain a cantharidin solvent carrier, and the cantharidin solvent carrier and a pharmaceutically acceptable carrier or excipient are prepared into antiviral and antibacterial drugs in various dosage forms. The medicine can be used for preventing and treating the novel coronavirus infection, and the cantharidin solvent carrier can also be used as a solution for preparing an ecological antibiotic inactivated vaccine for resisting novel coronaviruses..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Europäisches Patentamt - (2021) vom: 31. Dez. Zur Gesamtaufnahme - year:2021 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
WANG WEI [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2021-12-31, Last update posted on www.tib.eu: 2022-11-24, Last updated: 2023-02-09 |
---|
Patentnummer: |
CN113855668 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA016072006 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA016072006 | ||
003 | DE-627 | ||
005 | 20230504065451.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230216s2021 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA016072006 | ||
035 | |a (EPA)CN113855668 | ||
035 | |a (EPA)72110365 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a WANG WEI |e verfasserin |4 aut | |
245 | 1 | 0 | |a Antiviral and antibacterial cantharidin preparation, preparation method thereof and application of antiviral and antibacterial cantharidin preparation in prevention and treatment of novel coronavirus infection |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2021-12-31, Last update posted on www.tib.eu: 2022-11-24, Last updated: 2023-02-09 | ||
520 | |a The invention relates to an antiviral and antibacterial cantharidin preparation. The antiviral and antibacterial cantharidin preparation contains cantharidin as an effective drug component, the cantharidin is dissolved in an oil-water mutual solution or an oil-oil mutual solution to obtain a cantharidin solvent carrier, and the cantharidin solvent carrier and a pharmaceutically acceptable carrier or excipient are prepared into antiviral and antibacterial drugs in various dosage forms. The medicine can be used for preventing and treating the novel coronavirus infection, and the cantharidin solvent carrier can also be used as a solution for preparing an ecological antibiotic inactivated vaccine for resisting novel coronaviruses. | ||
650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
650 | 4 | |a che | |
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a 615 | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2021) vom: 31. Dez. |
773 | 1 | 8 | |g year:2021 |g day:31 |g month:12 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/72110365/publication/CN113855668A1?q=CN113855668 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
912 | |a SSG-OLC-PHA | ||
936 | u | w | |j 2021 |b 31 |c 12 |
951 | |a AR | ||
952 | |j 2021 |b 31 |c 12 |